These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23082981)

  • 1. Targeting the nuclear transport machinery by rational drug design.
    Mao L; Yang Y
    Curr Pharm Des; 2013; 19(12):2318-25. PubMed ID: 23082981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear Export as a Novel Therapeutic Target: The CRM1 Connection.
    Lu C; Figueroa JA; Liu Z; Konala V; Aulakh A; Verma R; Cobos E; Chiriva-Internati M; Gao W
    Curr Cancer Drug Targets; 2015; 15(7):575-92. PubMed ID: 26324128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel reversible selective inhibitor of nuclear export shows that CRM1 is a target in colorectal cancer cells.
    Niu M; Chong Y; Han Y; Liu X
    Cancer Biol Ther; 2015; 16(7):1110-8. PubMed ID: 25996664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of CRM1-dependent nuclear export sensitizes malignant cells to cytotoxic and targeted agents.
    Turner JG; Dawson J; Cubitt CL; Baz R; Sullivan DM
    Semin Cancer Biol; 2014 Aug; 27():62-73. PubMed ID: 24631834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Exportin-1 is a Target for Combined Therapy of HIV and AIDS Related Lymphoma.
    Boons E; Vanstreels E; Jacquemyn M; Nogueira TC; Neggers JE; Vercruysse T; van den Oord J; Tamir S; Shacham S; Landesman Y; Snoeck R; Pannecouque C; Andrei G; Daelemans D
    EBioMedicine; 2015 Sep; 2(9):1102-13. PubMed ID: 26501108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. XPO1-dependent nuclear export as a target for cancer therapy.
    Azizian NG; Li Y
    J Hematol Oncol; 2020 Jun; 13(1):61. PubMed ID: 32487143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression, function, and targeting of the nuclear exporter chromosome region maintenance 1 (CRM1) protein.
    Ishizawa J; Kojima K; Hail N; Tabe Y; Andreeff M
    Pharmacol Ther; 2015 Sep; 153():25-35. PubMed ID: 26048327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome Region Maintenance 1 (XPO1/CRM1) as an Anticancer Target and Discovery of Its Inhibitor.
    Liu S; Qiao W; Sun Q; Luo Y
    J Med Chem; 2021 Nov; 64(21):15534-15548. PubMed ID: 34669417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atomic basis of CRM1-cargo recognition, release and inhibition.
    Fung HY; Chook YM
    Semin Cancer Biol; 2014 Aug; 27():52-61. PubMed ID: 24631835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRM1 is a direct cellular target of the natural anti-cancer agent plumbagin.
    Liu X; Niu M; Xu X; Cai W; Zeng L; Zhou X; Yu R; Xu K
    J Pharmacol Sci; 2014; 124(4):486-93. PubMed ID: 24739265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of CRM1-NES affinity with nuclear export activity.
    Fu SC; Fung HYJ; Cağatay T; Baumhardt J; Chook YM
    Mol Biol Cell; 2018 Aug; 29(17):2037-2044. PubMed ID: 29927350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer Therapy with Nanoparticle-Medicated Intracellular Expression of Peptide CRM1-Inhibitor.
    Sui M; Xiong M; Li Y; Zhou Q; Shen X; Jia D; Gou M; Sun Q
    Int J Nanomedicine; 2021; 16():2833-2847. PubMed ID: 33883894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-Guided Design of the First Noncovalent Small-Molecule Inhibitor of CRM1.
    Lei Y; An Q; Shen XF; Sui M; Li C; Jia D; Luo Y; Sun Q
    J Med Chem; 2021 May; 64(10):6596-6607. PubMed ID: 33974430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The myxobacterial metabolite ratjadone A inhibits HIV infection by blocking the Rev/CRM1-mediated nuclear export pathway.
    Fleta-Soriano E; Martinez JP; Hinkelmann B; Gerth K; Washausen P; Diez J; Frank R; Sasse F; Meyerhans A
    Microb Cell Fact; 2014 Jan; 13():17. PubMed ID: 24475978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The export receptor Crm1 forms a dimer to promote nuclear export of HIV RNA.
    Booth DS; Cheng Y; Frankel AD
    Elife; 2014 Dec; 3():e04121. PubMed ID: 25486595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ratjadone and leptomycin B block CRM1-dependent nuclear export by identical mechanisms.
    Meissner T; Krause E; Vinkemeier U
    FEBS Lett; 2004 Oct; 576(1-2):27-30. PubMed ID: 15474004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of Potent Covalent CRM1 Inhibitors Via a Customized Structure-Based Virtual Screening Pipeline and Bioassays.
    Liu H; Shen C; Li H; Hou T; Yang Y
    J Chem Inf Model; 2024 Oct; 64(19):7422-7431. PubMed ID: 39361942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear import and export inhibitors alter capsid protein distribution in mammalian cells and reduce Venezuelan Equine Encephalitis Virus replication.
    Lundberg L; Pinkham C; Baer A; Amaya M; Narayanan A; Wagstaff KM; Jans DA; Kehn-Hall K
    Antiviral Res; 2013 Dec; 100(3):662-72. PubMed ID: 24161512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exportin 1 inhibition as antiviral therapy.
    Uddin MH; Zonder JA; Azmi AS
    Drug Discov Today; 2020 Oct; 25(10):1775-1781. PubMed ID: 32569833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear export of proteins and drug resistance in cancer.
    Turner JG; Dawson J; Sullivan DM
    Biochem Pharmacol; 2012 Apr; 83(8):1021-32. PubMed ID: 22209898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.